Efficacy and safety of bivalirudin bridging enoxaparin versus fondaparinux in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: evidence from a single-center study
1 |
Department of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, China |
CORRESPONDING AUTHOR
Jian An
Shanxi Cardiovascular Hospital, China
Submission date: 2022-09-26
Final revision date: 2022-12-02
Acceptance date: 2022-12-09
Online publication date: 2023-01-13
Publication date: 2023-01-01